MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/tme.13094

Медицинская библиотека · Transfusion medicine (Oxford, England) · 2024

Characterising practice patterns of human derived, lyophilized coagulation concentrates within the trauma quality improvement program registry.

Rosenthal Chester A, Douin David J, Cohen Mitch J, Rizzo Julie A, April Michael D, Schauer Steven G

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

We seek to describe the current practice pattern use of prothrombin complex concentrate (PCC) and fibrinogen concentrate (FC) in trauma patients.

BACKGROUND

Trauma-induced coagulopathy (TIC) and endotheliopathy of trauma (EOT) contribute significantly to mortality from traumatic haemorrhage. FC, and 4-factor PCC are potential treatments for EOT and TIC, respectively.

MATERIALS AND

METHODS

We obtained data from the Trauma Quality Improvement Program (TQIP) registry and identified patients who received either PCC or FC using procedural codes. We used descriptive statistics to characterise practice patterns of these products.

RESULTS

There were 6 714 002 total encounters within the TQIP from 2017 to 2022, of which 10 589 received PCC and 3009 received FC. Of the recipients, there were 35 that received both products. There were 44 that received both. The median age of PCC recipients was 77 (69-84) with 19 patients <15 years of age with the youngest being 2 years of age. There was a general upward trend in the number of facilities with documented use of PCC: 155/744, 168/766, 189/764, 206/780, 234/795, and 235/816, respectively. The median age of FC recipients was 57 (32-75) with 48 patients <15 years of age with the youngest being 1 year of age. There was a minor downward trend in the number of facilities that had documented use of FC: 55, 44, 39, 32, 38 and 40.

CONCLUSIONS

The administration of PCC and FC remains uncommon, although there appears to be an upward trend of PCC use. Most PCC use appeared to be for anticoagulation reversal in the setting of head trauma. Data guiding the use of these products are necessary as these products become more recognised as adjuncts to traumatic haemorrhage control.

Для цитирования: Rosenthal Chester A, Douin David J, Cohen Mitch J, Rizzo Julie A, April Michael D, Schauer Steven G. Characterising practice patterns of human derived, lyophilized coagulation concentrates within the trauma quality improvement program registry.. Transfusion medicine (Oxford, England). 2024. DOI: 10.1111/tme.13094.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.